Cathie Wood Vascular Biogenics Ltd. Transaction History

Ark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$1.15 - $1.97 $1.53 Million - $2.62 Million	-1,330,206 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$1.92 - $2.53 $121,447 - $160,032	-63,254 Reduced 4.54%	1,330,206 $2.62 Million
Q3 2021 Nov 12, 2021	BUY	$1.94 - $2.55 $2.7 Million - $3.55 Million	1,393,460 New	1,393,460 $2.86 Million
Q2 2018 Aug 07, 2018	SELL	$2.05 - $3.0 $154,475 - $226,062	-75,354 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$2.27 - $8.5 $74,614 - $279,395	32,870 Added 77.37%	75,354 $173,000
Q4 2017 Feb 12, 2018	BUY	$5.65 - $9.0 $240,034 - $382,356	42,484	42,484 $302,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.